PULMOVET A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  20.5% 18.3% 15.8% 17.6% 13.7%  
Credit score (0-100)  6 8 11 8 15  
Credit rating  B B BB B BB  
Credit limit (kDKK)  -0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  9.5 -2.6 -6.4 -5.4 -3.6  
EBITDA  9.5 -2.6 -6.4 -5.4 -3.6  
EBIT  -331 -14.2 -6.4 -5.4 -3.6  
Pre-tax profit (PTP)  -318.0 -0.7 -6.4 -5.4 -3.6  
Net earnings  -548.0 -11.7 -6.4 -5.4 -3.6  
Pre-tax profit without non-rec. items  -318 -0.7 -6.4 -5.4 -3.6  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  40.2 28.4 22.1 16.7 13.1  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  46.1 42.8 44.3 36.9 36.5  

Net Debt  -0.1 -0.5 -1.7 -1.0 -0.5  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  9.5 -2.6 -6.4 -5.4 -3.6  
Gross profit growth  0.0% 0.0% -141.5% 15.2% 33.2%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  46 43 44 37 36  
Balance sheet change%  -92.2% -7.2% 3.7% -16.7% -1.3%  
Added value  9.5 -2.6 -6.4 -5.4 -3.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -341 -12 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -4.0 -5.0 -5.0 -5.0 -5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -3,489.1% 541.1% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -99.4% -32.1% -14.6% -13.3% -9.8%  
ROI %  -101.2% -41.5% -25.2% -27.8% -24.2%  
ROE %  -174.4% -34.1% -25.2% -27.9% -24.2%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  87.1% 66.5% 49.8% 45.2% 35.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -1.0% 18.2% 26.2% 19.0% 14.9%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  7.8 3.0 2.0 1.8 1.6  
Current Ratio  7.8 3.0 2.0 1.8 1.6  
Cash and cash equivalent  0.1 0.5 1.7 1.0 0.5  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 1,371.6 2,368.8  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  40.2 28.4 22.1 16.7 13.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0